The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial

BACKGROUND: COVID-19 pandemic has made the disease a major global problem by creating a significant burden on health, economic, and social status. To date, there are no effective and approved medications for this disease. Curcumin as an anti-inflammatory agent can have a positive effect on the contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Askari, Gholamreza, Sahebkar, Amirhossein, Soleimani, Davood, Mahdavi, Atena, Rafiee, Sahar, Majeed, Muhammed, Khorvash, Farzin, Iraj, Bijan, Elyasi, Mahshid, Rouhani, Mohammad Hossein, Bagherniya, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167899/
https://www.ncbi.nlm.nih.gov/pubmed/35668500
http://dx.doi.org/10.1186/s13063-022-06375-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167899/
https://www.ncbi.nlm.nih.gov/pubmed/35668500
http://dx.doi.org/10.1186/s13063-022-06375-w

Ejemplares similares